No Detail Found!

Clinical efficacy and safety of fluticasone/salmeterol inhalation powder combined with huaiqihuang granules in the treatment of children with cough variant asthma

Author(s)
Junting Liu Child Health Department, CangZhou Central Hospital,Cangzhou, Hebei,China
Jing Yang Department of Cardiology, CangZhou Central Hospital,Cangzhou, Hebei,China
Shiyu Du Medical Insurance Division Fee Section, CangZhou Central Hospital,Cangzhou, Hebei,China
Run Guo Department of Cardiology, CangZhou Central Hospital,Cangzhou, Hebei,China
Yuanyuan Guo Children's Rehabilitation Department, CangZhou Central Hospital,Cangzhou, Hebei,China
Chao Gao Child Health Department, CangZhou Central Hospital,Cangzhou, Hebei,China
Ruiqian Xi Child Health Department, CangZhou Central Hospital,Cangzhou, Hebei,China
Chao Chen Department of Cardiology, CangZhou Central Hospital,Cangzhou, Hebei,China
Abstract
This study was to evaluate the clinical efficacy and safety of fluticasone/ salmeterol inhalation powder plus Huaiqihuang Granules for children with cough variant asthma (CVA). From June 2019 to May 2021, 60 children with CVA were hospitalized to the Pediatrics Department of Cangzhou Central Hospital and randomized to the observation (fluticasone/salmeterol inhalation powder plus huaiqihuang granules) and control group (fluticasone/salmeterol inhalation powder) using the random number table method. The outcome measures include clinical efficacy, forced vital capacity (FVC), forced expiratory volume per second (FEV1), peak expiratory flow (PEF), FeNO, high-sensitivity Creactive protein (hs-CRP), interleukin-17 (IL-17) and IL-23, airway anatomical indicators, and T lymphocyte subsets levels. Both groups exhibited remarkable improvements in FVC, FEV1, PEF and FeNO and hs-CRP, IL-17 and IL-23, with higher FVC, FEV1 and PEF and lower FeNO, hs-CRP, IL-17 and IL-23 in the observation group (all P<0.05). Significantly higher levels of CD4+ and CD4+/CD8+ were observed in the observation group versus control group, but lower airway wall thickness, basement membrane thickness, total airway wall area, and CD8+ in the observation group (all P<0.05). Fluticasone/salmeterol inhalation powder plus Huaiqihuang Granules improves lung function, FeNO and airway inflammation in children with CVA, and boosts cellular and humoral immune function.
Publication Details
Page(s) 1001-1007
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S3, Year: 2023

Request the full text from PASTIC

Keywords
Immune system, inflammatory factors, Cough variant asthma, huaiqihuang granules, fluticasone/salmeterol inhalation powder
References
Anderson SD,Daviskas E,Brannan JD,Chan HK .2018 .Repurposing excipients as active inhalation agents: The mannitol story. Adv. Drug Deliv. Rev., 133 : 45-56.
Chałubiński M,Gajewski A,Kowalski ML .2020 .The relationship between human corona viruses, asthma and allergy-An unresolved dilemma. Clin. Exp. Allergy, 50(10) : 1122-1126.
Che KF,Tengvall S,Linden A .2021 .Interleukin-26 in host defense and inflammatory disorders of the airways. Cytokine Growth Factor Rev., 57 : 1-10.
Choi Y,Jang J,Park HS .2020 .Pulmonary surfactants: A new therapeutic target in asthma. Curr. Allergy Asthma Rep, 20(11) : 70.
Han X,Krempski JW,Nadeau K JW .2020 .Advances and novel developments in mechanisms of allergic inflammation. Allergy, 75(12) : 3100-3111.
Long He .2021 .Clinical analysis of self-made Yiqi Qutan prescription in the treatment of variant bronchial asthma with Qi deficiency and phlegm stasis. Chin Med, 19(20) : 84-85.
Hong H,Liao S,Chen F,Yang Q,Wang DY .2020 .Role of IL-25, IL-33 and TSLP in triggering united airway diseases toward type 2 inflammation. , 75(11) : 2794-2804.
Kroes JA,Zielhuis SW,van Roon EN,Ten Brinke A .2020 .Prediction of response to biological treatment with monoclonal antibodies in severe asthma. Biochem Pharmacol, 179 : 113978.
Li E,Knight JM,Wu Y JM .2019 .Airway mycosis in allergic airway disease. Adv. Immunol., 142 : 85-140.
Louati N,Rekik T,Menif H,Gargouri J .2019 .Blood lymphocyte T subsets reference values in blood donors by flow cytometry. Tunis Med, 97(2) : 327-334.
Maciag MC,Phipatanakul W .2022 .Prevention of asthma: Targets for intervention. Chest, 158(3) : 913-922.
Mukhopadhyay A,Waked M,Gogtay J,Gaur V .2020 .Comparing the efficacy and safety of formoterol/budesonide pMDI versus its monocomponents and other LABA/ICS in patients with asthma. Respir. Med, 170 : 106055.
Papanicolaou A,Wang H,Satzke C,Vlahos R,Wilson N,Bozinovski S N .2020 .Novel therapies for pneumonia-associated severe asthma phenotypes. Trends Mol. Med, 26(11) : 1047-1058.
Portincasa P,Krawczyk M,Smyk W,Lammert F,Di Ciaula A F .2020 .COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics. Eur. J. Clin. Invest, 50(10) : e13338.
Porcaro F,Ullmann N,Allegorico A,Di Marco A,Cutrera R .2020 .Difficult and severe asthma in children. Children (Basel), 7(12) : 286.
Preston KB,Randolph TW .2021 .Stability of lyophilized and spray dried vaccine formulations. Adv. Drug Deliv. Rev., 171 : 50-61.
Rocha DMUP,Caldas APS,da Silva BP,Hermsdorff HHM,Alfenas RCG .2019 .Effects of blueberry and cranberry consumption on type 2 diabetes glycemic control: A systematic review. Crit. Rev. Food Sci, Nutr, 59(11) : 1816-1828.
Sobieraj DM,Weeda ER,Nguyen E,Coleman CI,White CM,Lazarus SC,Blake KV,Lang JE,Baker WL .2018 .Association of inhaled corticosteroids and longacting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: A systematic review and meta-analysis. JAMA, 319(14) : 1485-1496.
Santus P,Radovanovic D,Pecchiari M,Ferrando M,Tursi F,Patella V,Braido F V .2020 .The relevance of targeting treatment to small airways in asthma and COPD. Respir. Care, 65(9) : 1392-1412.
Sharma S,Hashmi MF,Chakraborty RK .2021 .Treasure Island (FL): StatPearls Publishing; 2021 Jan. , 30285350 : .
Shen WF,Liu MX,Cao J .2022 .Clinical study on the adjuvant treatment of cough variant asthma with Fengsheng contracture and acute syndrome with Qufengzhike recipe. Inter. J. Tradit Chin. Med, 43(12) : 1179-1183.
Wang Y,Yang YM .2021 .Research overview of Sanao decoction in the treatment of children with cough variant asthma. Chin. Ethnic. Folk Med, 30(24) : 62-65.
Weers JG,Miller DP,Tarara TE .2019 .Spray-dried pulmosphere™ formulations for inhalation comprising crystalline drug particles. AAPS Pharm. Sci. Tech, 20(3) : 103.
Yao Y,Wang H,Liu Z H .2020 .Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin. Exp. Allergy, 50(12) : 1313-1324.
Zheng YF,Wu Y,Mao WP Y .2021 .Qufeng Sanhanzhisou prescription combined with western medicine in the treatment of 49 cases of cough variant asthma in children. Chin. Sci. Tech Tradit. Chin. Med, 28(06) : 997-999.
Zhong Y,Cai HJ,Cao JB .2022 .Clinical study on the treatment of cough variant asthma with Kangmin Zhenke Decoction. Henan. Chin Med, 42(06) : 923-927.
0

Citations

0

Downloads

79

Views